July 28, 2011
Genzyme Seeks European Drug Approval
Genzyme, the division of French drug maker Sanofi Aventis with much of its operations in the MetroWest area, and its partner, California-based Isis Pharmaceuticals Inc., announced that they are applying to market a cholesterol-lowering drug in Europe.
The companies are seeking approval from the European Medicines Agency for the drug mipomersen to be used on patients with a genetic disease that results in high LDL-C levels. The disease puts patients at risk for premature heart disease.
The companies would market the drug under the name Kynamro. Isis developed the drug and licensed it to Genzyme.
WBJ Web Partners
Most Recent
Most Recent
0 Comments